CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia

Haematologica. 2019 Mar;104(3):e100-e103. doi: 10.3324/haematol.2018.192757. Epub 2018 Sep 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • ADP-ribosyl Cyclase 1 / antagonists & inhibitors*
  • Adult
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Female
  • Humans
  • Leukemia, Myeloid, Acute / diagnosis
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / metabolism*
  • Male
  • Membrane Glycoproteins / antagonists & inhibitors*
  • Molecular Targeted Therapy*
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / metabolism*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Membrane Glycoproteins
  • CD38 protein, human
  • ADP-ribosyl Cyclase 1